Hubei Biocause Pharmaceutical Co., Ltd. (SHE: 000627)
China
· Delayed Price · Currency is CNY 3.960
-0.410 (-9.38%)
Jan 3, 2025, 3:04 PM CST
Hubei Biocause Pharmaceutical Revenue
Hubei Biocause Pharmaceutical had revenue of 4.54B CNY in the quarter ending September 30, 2024, a decrease of -41.47%. This brings the company's revenue in the last twelve months to 40.70B, down -22.90% year-over-year. In the year 2023, Hubei Biocause Pharmaceutical had annual revenue of 48.28B, down -2.10%.
Revenue (ttm)
40.70B
Revenue Growth
-22.90%
P/S Ratio
0.49
Revenue / Employee
23.06M
Employees
1,765
Market Cap
19.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 48.28B | -1.03B | -2.10% |
| Jan 1, 2023 | 49.31B | 614.72M | 1.26% |
| Jan 1, 2022 | 48.70B | 7.57B | 18.40% |
| Dec 31, 2020 | 41.13B | -8.54B | -17.20% |
| Dec 31, 2019 | 49.67B | 19.79B | 66.25% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Merchants Bank | 293.75B |
| Ping An Insurance (Group) Company of China | 940.90B |
| Industrial Bank | 145.72B |
| CITIC Securities Company | 61.34B |
| East Money Information Co.,Ltd. | 9.79B |
| Shanghai Pudong Development Bank | 99.62B |
| China Pacific Insurance (Group) | 296.25B |
| Ping An Bank | 100.94B |